Bacterial arthritis
MONDO:0004471The inflammation of one or more joints caused by a bacterial infection within the joint space. Symptoms include pain, stiffness, and decreased range of motion in the affected joint.
Also known as: infectious arthritis, pyogenic arthritis, septic arthritis
118 clinical trials for this condition and its sub-types, 24 tagged with Bacterial arthritis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bacterial arthritis
-
Periprosthetic joint infection 76 trials
-
Escherichia coli discitis 0 trials
-
Gonococcal infection of joint 0 trials
1 sub-type
- Gonococcal synovitis 0 trials
-
Salmonella discitis 0 trials
-
Staphylococcus discitis 0 trials
-
Streptococcus pneumoniae discitis 0 trials
-
Can telemedicine bring IV antibiotics home?
Disease control OngoingThis trial tests a new model where patients with infections receive intravenous antibiotics at home instead of staying in the hospital. Nurses from a municipal response team visit the patient, while hospital doctors oversee the treatment remotely using telemedicine and welfare te…
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Bone-Delivered antibiotics could spare joint infection patients from repeat surgeries
Disease control By invitation onlyThis study tests whether giving antibiotics directly into the bone during a standard cleaning surgery can better control joint infections and reduce the need for additional major surgeries. About 100 adults with infected knee or hip replacements will receive this targeted antibio…
Phase 4 • Sponsor: OrthoCarolina Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New daily pill could simplify tough bone infection treatment
Disease control OngoingThis study tests a new antibiotic called omadacycline, taken once a day by mouth, against standard antibiotics for bone and joint infections. About 180 adults with these infections will be randomly assigned to receive either omadacycline or the usual care. The goal is to see if o…
Phase 2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC